Original Research
Published on 29 Sep 2021
Pioneering BRCA1/2 Point-Of-Care Testing for Integration of Germline and Tumor Genetics in Breast Cancer Risk Management: A Vision for the Future of Translational Pharmacogenomics
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.619817
- 7,383 views
- 14 citations
